Skip to content
Equity Capital Market
  • Privacy Policy
  • Start Here
  • Research
    • LPTH case study
    • PLUG case study
    • STDN case study
  • IPO & Public Offerings
  • Economy & Macro
  • Latest
  • Stock Market
  • Market Education
  • Energy & Commodities
  • Capital Markets
  • Federal Reserve & Rates
  • About
  • Contact

ipo market 2026

US IPO Market 2026: $145.8B Raised, 6x Last Year

September 12, 2026August 27, 2026 by Bruno M.
US IPO Market 2026: $145.8B Raised, 6x Last Year

US IPOs have raised $145.8B YTD 2026 — a 542% jump from 2025 — with SpaceX, SK hynix and Cerebras driving mega-deal proceeds despite 25% fewer listings.

Categories Market Trend Tags capital markets, cerebras ipo, ipo market 2026, renaissance capital, sk hynix ipo, spacex ipo

Jersey Mike’s Prices $1B NYSE IPO at $23; JMKE Debuts Today

September 12, 2026July 30, 2026 by Bruno M.
Jersey Mike’s Prices $1B NYSE IPO at $23; JMKE Debuts Today

Blackstone-backed Jersey Mike’s priced its NYSE IPO at $23/share, raising about $1B at a $7.3B equity valuation; JMKE begins trading July 30.

Categories Stock Market Tags Blackstone, capital markets, ipo market 2026, jersey mike's ipo, jmke, sponsor exit

U.S. IPOs Hit $251B First-Half Record, Pacing for 2021 Beat

September 12, 2026June 30, 2026 by Bruno M.
U.S. IPOs Hit $251B First-Half Record, Pacing for 2021 Beat

U.S. issuers raised $251B through June 26 — the biggest H1 on record — led by SpaceX’s $86.2B IPO and Alphabet’s $85B AI raise. Inside the numbers.

Categories Artificial Intelligence, Market Trend Tags ai infrastructure ipos, alphabet ai raise, capital markets, ipo market 2026, renaissance capital ipo, spacex ipo

GLP-1 Startup Kailera Leads Biotech IPO Revival With $625M Deal

September 12, 2026May 3, 2026 by Bruno M.
GLP-1 Startup Kailera Leads Biotech IPO Revival With $625M Deal

Kailera Therapeutics’ $625M GLP-1 IPO anchors a Q2 2026 healthcare listing wave, with Hemab Therapeutics, Avalyn Pharma, and peers all jumping 52-89% from their offer prices.

Categories Stock Market Tags biotech IPO, capital markets, GLP-1 obesity, ipo market 2026, kailera therapeutics

Cerebras Systems Files for $40 Billion IPO

September 12, 2026May 2, 2026 by Bruno M.
Cerebras Systems Files for $40 Billion IPO

Cerebras Systems targets a $40B valuation in its IPO, backed by a landmark OpenAI deal and AWS Bedrock integration that transformed its revenue base.

Categories IPO & Public Offerings Tags ai chip ipo, ai inference chips, capital markets, cerebras systems ipo, ipo market 2026

Bill Ackman’s $5B Pershing Square IPO Falls Short of $25B Goal

September 12, 2026April 29, 2026 by Bruno M.
Bill Ackman’s $5B Pershing Square IPO Falls Short of $25B Goal

Bill Ackman’s Pershing Square raises $5B in a dual NYSE IPO but shares sink ~18% on debut as retail demand misses the original $25B target.

Categories IPO & Public Offerings Tags Bill Ackman, capital markets, closed-end fund, ipo market 2026, pershing square ipo

Explore ECMSource

New here? Begin with our guide to the site, then explore the subjects that match what you want to understand.

  • Start Here
  • Market Education
  • Stock Market
  • Capital Markets
  • Federal Reserve & Rates

Recent Posts

  • Is the Stock Market Open on Columbus Day? Market Split Explained
  • Vaxcyte Closes $1.1B Dual Equity and Convertible Notes Deal
  • Stock Split Accounting: Par Value & Balance Sheet Effects
  • BMW Lease Trust Prices $1.25B Auto ABS Across 5 Tranches
  • Gran Tierra Holders Approve $1.33B Latin America Asset Sale

Subscribe to Our Newsletter

Oh hi there 👋
It’s nice to meet you.

Sign up to receive awesome content in your inbox, every month.

We don’t spam! Read our privacy policy for more info.

Check your inbox or spam folder to confirm your subscription.

  • Privacy Policy
  • Editorial Policy
  • Corrections Policy
  • Financial Disclaimer
  • Contact
  • About Bruno M.
  • Investor Tools
© 2026 Equity Capital Market • Built with GeneratePress